|
|
|
|
|
|
ȭ(Poorly differentiated thyroid carcinoma, insular, solid, trabecular) |
|
ȭ ȭϰ ̺ȭ ߰ Ư ̴ ǵȴ. ħ ħ ϰ 5cm ̻ ϰ ε ħ ִ. ܽ 55̸ 2:1, ſ ӻ ġ 찡 ϴ. ݺ ̴ ϴ. |
|
|
|
|
|
|
|
|
|
|
|
̺ȭ({, Undifferentiated or anaplastic thyroid carcinoma}) |
|
̺ȭ ü 1~2% ϸ 밳 60 ȯڿ ַ ϰ ణ ϴ. Ǹ ʰ ϰ ħϸ ӵ . ֺ Ǻ, , Ű, , ĵ ĵ ħ ϰ ̴ ʱ Ͽ ַ , ħѴ.
ξ Ȥ Ǵµ, ̴ ̷ ̺ȭ ̾ ûѴ. ֺ ħ ϱ ż ġḦ ؾ Ѵ. ܺ 缱ġ ̿ ġᰡ ̿ǰ κ Ͽ Ⱓ 6 ̴̳. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(medullary thyroid carcinoma) |
|
ü 10% ̸̸ 幰. ο C ϴ Į к Ư¡̴. ħϿ ٸ ̰ ϸ Ҹ Ѵ. , ̵ ϴ.
20% ̸ Ѵ. ϴ Ȥ ٹ߳к(MEN) 2A,2B Ϻ ϸ Ư¡ ϴ C ְ 翱 Ѵ. ϴ C ñ ϸ 90% ̻ ġ ִ.
ڷ
(1)ܽ
(2)
(3)ܽ
(4) ũ
(5) ħ
(6)ħ
(7)Į 鿪 ƹз̵
(8) ȯ
(9) Į ġ
پ νŻı(paraneoplastic syndrome) ִ. 翡 ACTH кϴ Cushing syndrome ְ PG,kinin,VIP к ־ ȫ 簡 1/3 ȯڿ ϸ κ Ѵ. MEN-2A ΰ ݵ ְ ΰ ٴ ΰ ̴. MEN-2B , , ٹ Ű Բ Marfan syndrome ü ̳ ΰ ʴ´.
Į ӻ ܵ ȯڿ Ǿ Į ̰ų 迪 ִ ŸƮ Ȥ Į ֻϿ Į к ְ ̳ C ִ Į к Ȯ ִ.
|
|
|
|
|
|
|
|
|
|
|
|
(Thyroid lymphoma) |
|
ſ 幰 ü 2% ̸ ϸ 60뿡 ְ ̰ 1:3 ڿ ϴ. ڶ 뼺 ֺ Ǿ й ʷѴ.
ڰ鿪 (mucosa-associated lymphoid tissue, MALT) Ư¡ ̹Ƿ κ MALT̶ ִ. ȭп ʿϸ ο ѵ ġ Ұ߿ ٰϿ Ѵ. |
|
|
|
|
|
|
|
|